Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Director departure
Appointed director

GENELINK INC (GNLK) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/22/2014 8-K Quarterly results
11/14/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
07/08/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/11/2013 8-K Submission of Matters to a Vote of Security Holders, Other Events
02/11/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/24/2012 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
07/16/2012 8-K Form 8-K - Current report
05/11/2012 8-K/A Form 8-K - Current report [amend]
05/10/2012 8-K Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Financial State...
Docs: "GeneLink Reports 2011 Financial Results 2010 Re-audited and Restated"
05/04/2012 8-K/A Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
Docs: "Letter of Cross, Fernandez & Riley LLP filed pursuant to Item 304 of Regulation S-K"
04/27/2012 8-K Form 8-K - Current report
03/20/2012 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
Docs: "Letter of Cross, Fernandez and Riley, LLC",
"Research report of Cross, Fernandez and Riley, LLC"
03/09/2012 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
Docs: "Letter of Buckno Lisicky & Company, P.C. filed pursuant to Item 304(a)(3) of Regulation S-K"
02/16/2012 8-K Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits
Docs: "GENELINK BIOSCIENCES COMPLETES SALE OF GENEWIZE LIFE SCIENCES"
01/31/2012 8-K Submission of Matters to a Vote of Security Holders
10/17/2011 8-K Form 8-K - Current report
10/17/2011 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "License and Distribution Agreement between GeneLink, Inc. and Gene Elite, LLC",
"Warrant Purchase Agreement between GeneLink, Inc. and Gene Elite, LLC"
07/28/2011 8-K Form 8-K - Current report
05/26/2011 8-K Form 8-K - Current report
01/03/2011 8-K Form 8-K - Current report
05/21/2010 8-K Form 8-K - Current report
04/13/2010 8-K Form 8-K - Current report
02/24/2010 8-K Form 8-K - Current report
02/18/2010 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Gary J. Beeman Appointed CEO of GeneLink BioSciences, Inc. Sharon M. Tahaney Appointed President of GeneWize Life Sciences, Inc."
02/01/2010 8-K Resignation/termination of a director
12/28/2009 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "GeneLink BioSciences, Inc.,"
10/05/2009 8-K Form 8-K - Current report
08/19/2009 8-K Form 8-K - Current report
08/13/2009 8-K Other Events, Financial Statements and Exhibits
Docs: "GeneLink Receives Official Notice Regarding International Patent for Skin Health Assessment Orlando, Florida — August 13, 2009 — GeneLink, Inc. , a leading consumer genomics biotech company, announced today that it has received official notice from the Australian Patent Office that the patent claims set forth in its application for “Kits and Methods for Assessing Skin Health” are in condition for allowance. This is the fourth patent to be granted from a family of applications filed by GeneLink in the U.S. and abroad. A substantially similar patent issued in the United States in favor of GeneLink for this invention, which is a “first of its kind” skin-health assessment that identifies variations in key genes related to oxidative stress, skin aging, wrinkling and overall skin health; it is d..."
07/06/2009 8-K Appointed a new director
Docs: "GeneLink BioSciences, Inc. Names James Antal to Board of Directors Orlando, Florida - July 6, 2009 - GeneLink BioSciences, Inc. , has appointed James Antal to the Company's Board of Directors. Mr. Antal brings decades of financial and management experience to GeneLink and will serve as Chairman of the Audit Committee. “On behalf of GeneLink BioSciences, I would like to welcome Jim to the Board of Directors,” said Dr. Bernard Kasten, Executive Chairman. “We look forward to working with Jim as we focus on fully realizing the benefits of the tremendous opportunities available to GeneLink. Jim's financial and biotech experience will be an asset to GeneLink and its shareholders.” Mr. Antal is a member of the board of directors of Cleveland Biolabs, Inc. and SIGA Technologies, Inc. , biotechnolo..."
05/22/2009 8-K Quarterly results
Docs: "GeneLink Reports First Quarter Results Revenues Approximately $2.0M GeneWize Prepares for May and August Marketing Events"
05/13/2009 8-K Form 8-K -- Current report
04/01/2009 8-K Form 8-K -- Current report
03/04/2009 8-K Form 8-K -- Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy